Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: ABBVIE CORPORATION
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 02246896 | ABBVIE CORPORATION | ACTONEL | Human | Yes | Prescription | 1 | RISEDRONATE SODIUM (RISEDRONATE SODIUM HEMIPENTAHYDRATE) | 35 MG |
Marketed | 02316838 | ABBVIE CORPORATION | ACTONEL | Human | Yes | Prescription | 1 | RISEDRONATE SODIUM (RISEDRONATE SODIUM HEMIPENTAHYDRATE) | 150 MG |
Marketed | 02370417 | ABBVIE CORPORATION | ACTONEL DR | Human | Yes | Prescription | 1 | RISEDRONATE SODIUM (RISEDRONATE SODIUM HEMIPENTAHYDRATE) | 35 MG |
Marketed | 01968300 | ABBVIE CORPORATION | ACULAR | Human | Yes | Prescription | 1 | KETOROLAC TROMETHAMINE | 0.5 % / W/V |
Marketed | 02248722 | ABBVIE CORPORATION | ACULAR LS | Human | Yes | Prescription | 1 | KETOROLAC TROMETHAMINE | 0.4 % / W/V |
Marketed | 02369362 | ABBVIE CORPORATION | ACUVAIL | Human | Yes | Prescription | 1 | KETOROLAC TROMETHAMINE | 0.45 % / W/V |
Marketed | 00001147 | ABBVIE CORPORATION | ALBALON | Human | No | OTC | 1 | NAPHAZOLINE HYDROCHLORIDE | 0.1 % / W/V |
Marketed | 02236876 | ABBVIE CORPORATION | ALPHAGAN | Human | Yes | Prescription | 1 | BRIMONIDINE TARTRATE | 0.2 % / W/V |
Marketed | 02248151 | ABBVIE CORPORATION | ALPHAGAN P | Human | Yes | Prescription | 1 | BRIMONIDINE TARTRATE | 0.15 % / W/V |
Marketed | 02443910 | ABBVIE CORPORATION | BELKYRA | Human | Yes | Prescription | 1 | DEOXYCHOLIC ACID | 10 MG / ML |
Marketed | 01981501 | ABBVIE CORPORATION | BOTOX | Human | Yes | Prescription | 1 | ONABOTULINUMTOXINA | 100 UNIT / VIAL |
Marketed | 01981501 | ABBVIE CORPORATION | BOTOX | Human | Yes | Schedule D | 1 | ONABOTULINUMTOXINA | 100 UNIT / VIAL |
Marketed | 02531577 | ABBVIE CORPORATION | BOTOX | Human | Yes | Schedule D | 1 | ONABOTULINUMTOXINA | 50 UNIT / VIAL |
Marketed | 02531577 | ABBVIE CORPORATION | BOTOX | Human | Yes | Prescription | 1 | ONABOTULINUMTOXINA | 50 UNIT / VIAL |
Marketed | 02531585 | ABBVIE CORPORATION | BOTOX | Human | Yes | Schedule D | 1 | ONABOTULINUMTOXINA | 200 UNIT / VIAL |
Marketed | 02531585 | ABBVIE CORPORATION | BOTOX | Human | Yes | Prescription | 1 | ONABOTULINUMTOXINA | 200 UNIT / VIAL |
Marketed | 02243721 | ABBVIE CORPORATION | BOTOX COSMETIC | Human | Yes | Schedule D | 1 | ONABOTULINUMTOXINA | 100 UNIT / VIAL |
Marketed | 02243721 | ABBVIE CORPORATION | BOTOX COSMETIC | Human | Yes | Prescription | 1 | ONABOTULINUMTOXINA | 100 UNIT / VIAL |
Approved | 02531445 | ABBVIE CORPORATION | BOTOX COSMETIC | Human | Yes | Schedule D | 1 | ONABOTULINUMTOXINA | 50 UNIT / VIAL |
Marketed | 02398990 | ABBVIE CORPORATION | BYSTOLIC | Human | Yes | Prescription | 1 | NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE) | 2.5 MG |
Marketed | 02399008 | ABBVIE CORPORATION | BYSTOLIC | Human | Yes | Prescription | 1 | NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE) | 5 MG |
Marketed | 02399016 | ABBVIE CORPORATION | BYSTOLIC | Human | Yes | Prescription | 1 | NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE) | 10 MG |
Marketed | 02399024 | ABBVIE CORPORATION | BYSTOLIC | Human | Yes | Prescription | 1 | NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE) | 20 MG |
Cancelled Post Market | 00891738 | ABBVIE CORPORATION | CALCIJEX | Human | Yes | Prescription | 1 | CALCITRIOL | 1 MCG / ML |
Cancelled Post Market | 00891746 | ABBVIE CORPORATION | CALCIJEX | Human | Yes | Prescription | 1 | CALCITRIOL | 2 MCG / ML |
Marketed | 02248347 | ABBVIE CORPORATION | COMBIGAN | Human | Yes | Prescription | 2 | BRIMONIDINE TARTRATE | 0.2 % / W/V |
Marketed | 02417162 | ABBVIE CORPORATION | CONSTELLA | Human | Yes | Prescription | 1 | LINACLOTIDE | 145 MCG |
Marketed | 02417170 | ABBVIE CORPORATION | CONSTELLA | Human | Yes | Prescription | 1 | LINACLOTIDE | 290 MCG |
Marketed | 02469510 | ABBVIE CORPORATION | CONSTELLA | Human | Yes | Prescription | 1 | LINACLOTIDE | 72 MCG |
Marketed | 02292165 | ABBVIE CORPORATION | DUODOPA | Human | Yes | Prescription | 2 | CARBIDOPA (CARBIDOPA MONOHYDRATE) | 5 MG / ML |
Cancelled Post Market | 00778370 | ABBVIE CORPORATION | ENFLURANE | Human | Yes | Prescription | 1 | ENFLURANE | 99.9 % |
Marketed | 02542293 | ABBVIE CORPORATION | EPKINLY | Human | Yes | Schedule D | 1 | EPCORITAMAB | 5 MG / ML |
Marketed | 02542293 | ABBVIE CORPORATION | EPKINLY | Human | Yes | Prescription | 1 | EPCORITAMAB | 5 MG / ML |
Marketed | 02542307 | ABBVIE CORPORATION | EPKINLY | Human | Yes | Prescription | 1 | EPCORITAMAB | 60 MG / ML |
Marketed | 02542307 | ABBVIE CORPORATION | EPKINLY | Human | Yes | Schedule D | 1 | EPCORITAMAB | 60 MG / ML |
Marketed | 02440970 | ABBVIE CORPORATION | FETZIMA | Human | Yes | Prescription | 1 | LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) | 20 MG |
Marketed | 02440989 | ABBVIE CORPORATION | FETZIMA | Human | Yes | Prescription | 1 | LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) | 40 MG |
Marketed | 02440997 | ABBVIE CORPORATION | FETZIMA | Human | Yes | Prescription | 1 | LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) | 80 MG |
Marketed | 02441004 | ABBVIE CORPORATION | FETZIMA | Human | Yes | Prescription | 1 | LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) | 120 MG |
Marketed | 00247855 | ABBVIE CORPORATION | FML | Human | Yes | Prescription | 1 | FLUOROMETHOLONE | 0.1 % / W/V |
Cancelled Post Market | 02436027 | ABBVIE CORPORATION | HOLKIRA PAK | Human | Yes | Prescription | 4 | OMBITASVIR | 12.5 MG |
Marketed | 02258595 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02258595 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02458349 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02458349 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02458357 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02458357 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Approved | 02466872 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Prescription | 1 | ADALIMUMAB | 80 MG / 0.8 ML |
Approved | 02466872 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 80 MG / 0.8 ML |
Approved | 02474220 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Prescription | 1 | ADALIMUMAB | 80 MG / 0.8 ML |
Approved | 02474220 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 80 MG / 0.8 ML |
Approved | 02474255 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Prescription | 1 | ADALIMUMAB | 10 MG / 0.1 ML |
Approved | 02474255 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 10 MG / 0.1 ML |
Marketed | 02474263 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 20 MG / 0.2 ML |
Marketed | 02474263 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Prescription | 1 | ADALIMUMAB | 20 MG / 0.2 ML |
Cancelled Post Market | 02032384 | ABBVIE CORPORATION | ISOFLURANE USP | Human | Yes | Prescription | 1 | ISOFLURANE | 99.9 % |
Cancelled Post Market | 02243643 | ABBVIE CORPORATION | KALETRA | Human | Yes | Prescription | 2 | LOPINAVIR | 133.3 MG |
Marketed | 02243644 | ABBVIE CORPORATION | KALETRA | Human | Yes | Prescription | 2 | LOPINAVIR | 400 MG / 5 ML |
Marketed | 02285533 | ABBVIE CORPORATION | KALETRA | Human | Yes | Prescription | 2 | LOPINAVIR | 200 MG |
Marketed | 02312301 | ABBVIE CORPORATION | KALETRA | Human | Yes | Prescription | 2 | LOPINAVIR | 100 MG |
Marketed | 02350939 | ABBVIE CORPORATION | LATISSE | Human | Yes | Prescription | 1 | BIMATOPROST | 0.03 % / W/V |
Marketed | 02417456 | ABBVIE CORPORATION | LOLO | Human | Yes | Prescription | 3 | NORETHINDRONE ACETATE | 1 MG |
Marketed | 02324997 | ABBVIE CORPORATION | LUMIGAN RC | Human | Yes | Prescription | 1 | BIMATOPROST | 0.01 % / W/V |
Cancelled Post Market | 00727695 | ABBVIE CORPORATION | LUPRON | Human | Yes | Prescription | 1 | LEUPROLIDE ACETATE | 5 MG / ML |
Marketed | 00836273 | ABBVIE CORPORATION | LUPRON DEPOT | Human | Yes | Prescription | 1 | LEUPROLIDE ACETATE | 7.5 MG / SYR |
Marketed | 00884502 | ABBVIE CORPORATION | LUPRON DEPOT | Human | Yes | Prescription | 1 | LEUPROLIDE ACETATE | 3.75 MG / SYR |
Cancelled Pre Market | 02148722 | ABBVIE CORPORATION | LUPRON DEPOT | Human | Yes | Prescription | 1 | LEUPROLIDE ACETATE | 11.25 MG / VIAL |
Cancelled Pre Market | 02148730 | ABBVIE CORPORATION | LUPRON DEPOT | Human | Yes | Prescription | 1 | LEUPROLIDE ACETATE | 15 MG / VIAL |
Marketed | 02230248 | ABBVIE CORPORATION | LUPRON DEPOT | Human | Yes | Prescription | 1 | LEUPROLIDE ACETATE | 22.5 MG / SYR |
Marketed | 02239833 | ABBVIE CORPORATION | LUPRON DEPOT | Human | Yes | Prescription | 1 | LEUPROLIDE ACETATE | 30 MG / SYR |
Marketed | 02239834 | ABBVIE CORPORATION | LUPRON DEPOT | Human | Yes | Prescription | 1 | LEUPROLIDE ACETATE | 11.25 MG / SYR |
Marketed | 02467550 | ABBVIE CORPORATION | MAVIRET | Human | Yes | Prescription | 2 | PIBRENTASVIR | 40 MG |
Marketed | 02522470 | ABBVIE CORPORATION | MAVIRET | Human | Yes | Prescription | 2 | GLECAPREVIR | 50 MG / SACHET |
Cancelled Post Market | 02087308 | ABBVIE CORPORATION | MIVACRON | Human | Yes | Prescription | 1 | MIVACURIUM (MIVACURIUM CHLORIDE) | 2 MG / ML |
Cancelled Post Market | 02436396 | ABBVIE CORPORATION | MODERIBA | Human | Yes | Prescription | 1 | RIBAVIRIN | 200 MG |
Cancelled Post Market | 02436418 | ABBVIE CORPORATION | MODERIBA | Human | Yes | Prescription | 1 | RIBAVIRIN | 400 MG |
Cancelled Post Market | 02436426 | ABBVIE CORPORATION | MODERIBA | Human | Yes | Prescription | 1 | RIBAVIRIN | 600 MG |
Cancelled Post Market | 02229422 | ABBVIE CORPORATION | NIMBEX | Human | Yes | Prescription | 1 | CISATRACURIUM (CISATRACURIUM BESYLATE) | 2 MG / ML |
Cancelled Post Market | 02229137 | ABBVIE CORPORATION | NORVIR | Human | Yes | Prescription | 1 | RITONAVIR | 100 MG |
Cancelled Post Market | 02229145 | ABBVIE CORPORATION | NORVIR | Human | Yes | Prescription | 1 | RITONAVIR | 80 MG / ML |
Marketed | 02357593 | ABBVIE CORPORATION | NORVIR | Human | Yes | Prescription | 1 | RITONAVIR | 100 MG |
Cancelled Post Market | 02241480 | ABBVIE CORPORATION | NORVIR SEC | Human | Yes | Prescription | 1 | RITONAVIR | 100 MG |
Cancelled Post Market | 01924656 | ABBVIE CORPORATION | NUROMAX | Human | Yes | Prescription | 1 | DOXACURIUM (DOXACURIUM CHLORIDE) | 1 MG / ML |
Marketed | 02143291 | ABBVIE CORPORATION | OCUFLOX | Human | Yes | Prescription | 1 | OFLOXACIN | 0.3 % / W/V |
Marketed | 02481332 | ABBVIE CORPORATION | ORILISSA | Human | Yes | Prescription | 1 | ELAGOLIX (ELAGOLIX SODIUM) | 150 MG |
Marketed | 02481340 | ABBVIE CORPORATION | ORILISSA | Human | Yes | Prescription | 1 | ELAGOLIX (ELAGOLIX SODIUM) | 200 MG |
Marketed | 02363445 | ABBVIE CORPORATION | OZURDEX | Human | Yes | Prescription | 1 | DEXAMETHASONE | 0.7 MG |
Marketed | 00301175 | ABBVIE CORPORATION | PRED FORTE | Human | Yes | Prescription | 1 | PREDNISOLONE ACETATE | 1 % / W/V |
Marketed | 02533979 | ABBVIE CORPORATION | QULIPTA | Human | Yes | Prescription | 1 | ATOGEPANT | 10 MG |
Marketed | 02533987 | ABBVIE CORPORATION | QULIPTA | Human | Yes | Prescription | 1 | ATOGEPANT | 30 MG |
Marketed | 02533995 | ABBVIE CORPORATION | QULIPTA | Human | Yes | Prescription | 1 | ATOGEPANT | 60 MG |
Marketed | 02138670 | ABBVIE CORPORATION | REFRESH | Human | No | OTC | 1 | POLYVINYL ALCOHOL | 1.4 % / W/V |
Marketed | 00870153 | ABBVIE CORPORATION | REFRESH CELLUVISC | Human | No | OTC | 1 | CARBOXYMETHYLCELLULOSE SODIUM | 1 % / W/V |
Marketed | 02304015 | ABBVIE CORPORATION | REFRESH CONTACTS | Human | No | OTC | 1 | CARBOXYMETHYLCELLULOSE SODIUM | 0.5 % / W/V |
Marketed | 02315890 | ABBVIE CORPORATION | REFRESH EYE ALLERGY RELIEF | Human | No | OTC | 2 | ANTAZOLINE PHOSPHATE | 0.51 % |
Marketed | 00210889 | ABBVIE CORPORATION | REFRESH LACRI-LUBE | Human | No | OTC | 2 | MINERAL OIL | 42.5 % |
Marketed | 02244650 | ABBVIE CORPORATION | REFRESH LIQUIGEL | Human | No | OTC | 1 | CARBOXYMETHYLCELLULOSE SODIUM | 1 % / W/V |
Marketed | 02399148 | ABBVIE CORPORATION | REFRESH OPTIVE ADVANCED | Human | No | OTC | 3 | CARBOXYMETHYLCELLULOSE SODIUM | 0.5 % |
Marketed | 02425815 | ABBVIE CORPORATION | REFRESH OPTIVE ADVANCED SENSITIVE | Human | No | OTC | 3 | CARBOXYMETHYLCELLULOSE SODIUM | 0.5 % / W/W |
Marketed | 02435578 | ABBVIE CORPORATION | REFRESH OPTIVE FUSION | Human | No | OTC | 2 | CARBOXYMETHYLCELLULOSE SODIUM | 0.5 % / W/V |
Marketed | 02463652 | ABBVIE CORPORATION | REFRESH OPTIVE GEL DROPS | Human | No | OTC | 2 | CARBOXYMETHYLCELLULOSE SODIUM | 1 % / W/V |
Marketed | 02049260 | ABBVIE CORPORATION | REFRESH PLUS | Human | No | OTC | 1 | CARBOXYMETHYLCELLULOSE SODIUM | 0.5 % / W/V |
Marketed | 02231008 | ABBVIE CORPORATION | REFRESH TEARS | Human | No | OTC | 1 | CARBOXYMETHYLCELLULOSE SODIUM | 0.5 % / W/V |
Marketed | 02355655 | ABBVIE CORPORATION | RESTASIS | Human | Yes | Prescription | 1 | CYCLOSPORINE | 0.05 % / W/V |
Marketed | 02476835 | ABBVIE CORPORATION | RESTASIS MULTIDOSE | Human | Yes | Prescription | 1 | CYCLOSPORINE | 0.05 % / W/V |
Marketed | 02495155 | ABBVIE CORPORATION | RINVOQ | Human | Yes | Prescription | 1 | UPADACITINIB | 15 MG |
Marketed | 02520893 | ABBVIE CORPORATION | RINVOQ | Human | Yes | Prescription | 1 | UPADACITINIB | 30 MG |
Marketed | 02539721 | ABBVIE CORPORATION | RINVOQ | Human | Yes | Prescription | 1 | UPADACITINIB | 45 MG |
Marketed | 02112760 | ABBVIE CORPORATION | SALOFALK | Human | Yes | Prescription | 1 | MESALAZINE | 500 MG |
Marketed | 02112787 | ABBVIE CORPORATION | SALOFALK | Human | Yes | Prescription | 1 | MESALAZINE | 500 MG |
Marketed | 02112795 | ABBVIE CORPORATION | SALOFALK | Human | Yes | Prescription | 1 | MESALAZINE | 2 G / 60 G |
Marketed | 02112809 | ABBVIE CORPORATION | SALOFALK | Human | Yes | Prescription | 1 | MESALAZINE | 4 G / 60 G |
Marketed | 02242146 | ABBVIE CORPORATION | SALOFALK | Human | Yes | Prescription | 1 | MESALAZINE | 1000 MG |
Marketed | 02172763 | ABBVIE CORPORATION | SEVORANE AF | Human | Yes | Prescription | 1 | SEVOFLURANE | 99.97 % |
Marketed | 02487454 | ABBVIE CORPORATION | SKYRIZI | Human | Yes | Schedule D | 1 | RISANKIZUMAB | 75 MG / 0.83 ML |
Marketed | 02487454 | ABBVIE CORPORATION | SKYRIZI | Human | Yes | Prescription | 1 | RISANKIZUMAB | 75 MG / 0.83 ML |
Marketed | 02519283 | ABBVIE CORPORATION | SKYRIZI | Human | Yes | Schedule D | 1 | RISANKIZUMAB | 150 MG / 1 ML |
Marketed | 02519283 | ABBVIE CORPORATION | SKYRIZI | Human | Yes | Prescription | 1 | RISANKIZUMAB | 150 MG / 1 ML |
Marketed | 02519291 | ABBVIE CORPORATION | SKYRIZI | Human | Yes | Prescription | 1 | RISANKIZUMAB | 150 MG / 1 ML |
Marketed | 02519291 | ABBVIE CORPORATION | SKYRIZI | Human | Yes | Schedule D | 1 | RISANKIZUMAB | 150 MG / 1 ML |
Marketed | 02532093 | ABBVIE CORPORATION | SKYRIZI | Human | Yes | Schedule D | 1 | RISANKIZUMAB | 360 MG / 2.4 ML |
Marketed | 02532093 | ABBVIE CORPORATION | SKYRIZI | Human | Yes | Prescription | 1 | RISANKIZUMAB | 360 MG / 2.4 ML |
Marketed | 02532107 | ABBVIE CORPORATION | SKYRIZI | Human | Yes | Schedule D | 1 | RISANKIZUMAB | 60 MG / ML |
Marketed | 02532107 | ABBVIE CORPORATION | SKYRIZI | Human | Yes | Prescription | 1 | RISANKIZUMAB | 60 MG / ML |
Approved | 02546922 | ABBVIE CORPORATION | SKYRIZI | Human | Yes | Schedule D | 1 | RISANKIZUMAB | 90 MG / 1 ML |
Approved | 02546922 | ABBVIE CORPORATION | SKYRIZI | Human | Yes | Prescription | 1 | RISANKIZUMAB | 90 MG / 1 ML |
Marketed | 02100622 | ABBVIE CORPORATION | SULCRATE | Human | Yes | Prescription | 1 | SUCRALFATE | 1 G |
Marketed | 02103567 | ABBVIE CORPORATION | SULCRATE SUSPENSION PLUS | Human | Yes | Prescription | 1 | SUCRALFATE | 1 G / 5 ML |
Marketed | 02016109 | ABBVIE CORPORATION | SURVANTA | Human | Yes | Prescription | 1 | BERACTANT | 25 MG / ML |
Cancelled Post Market | 02245889 | ABBVIE CORPORATION | SYNAGIS | Human | Yes | Prescription | 1 | PALIVIZUMAB | 50 MG / VIAL |
Cancelled Post Market | 02245889 | ABBVIE CORPORATION | SYNAGIS | Human | Yes | Schedule D | 1 | PALIVIZUMAB | 50 MG / VIAL |
Cancelled Post Market | 02245890 | ABBVIE CORPORATION | SYNAGIS | Human | Yes | Prescription | 1 | PALIVIZUMAB | 100 MG / VIAL |
Cancelled Post Market | 02245890 | ABBVIE CORPORATION | SYNAGIS | Human | Yes | Schedule D | 1 | PALIVIZUMAB | 100 MG / VIAL |
Marketed | 00579408 | ABBVIE CORPORATION | TEARS PLUS | Human | No | OTC | 1 | POLYVINYL ALCOHOL | 1.4 % / W/V |
Cancelled Post Market | 02447711 | ABBVIE CORPORATION | TECHNIVIE | Human | Yes | Prescription | 3 | OMBITASVIR | 12.5 MG |
Marketed | 02439875 | ABBVIE CORPORATION | TOTAL DEFENSE + REPAIR BROAD SPECTRUM SPF 34 SUNSCREEN | Human | No | OTC | 3 | ZINC OXIDE | 8 % / W/W |
Marketed | 02439867 | ABBVIE CORPORATION | TOTAL DEFENSE + REPAIR BROAD SPECTRUM SPF 34 SUNSCREEN TINTED | Human | No | OTC | 4 | ZINC OXIDE | 8 % / W/W |
Cancelled Post Market | 00675210 | ABBVIE CORPORATION | TRACRIUM | Human | Yes | Prescription | 1 | ATRACURIUM BESYLATE | 10 MG / ML |
Marketed | 02532530 | ABBVIE CORPORATION | UBRELVY | Human | Yes | Prescription | 1 | UBROGEPANT | 50 MG |
Marketed | 02532581 | ABBVIE CORPORATION | UBRELVY | Human | Yes | Prescription | 1 | UBROGEPANT | 100 MG |
Cancelled Post Market | 02230409 | ABBVIE CORPORATION | ULTIVA | Human | Yes | Narcotic (CDSA I) | 1 | REMIFENTANIL (REMIFENTANIL HYDROCHLORIDE) | 1 MG |
Cancelled Post Market | 02230410 | ABBVIE CORPORATION | ULTIVA | Human | Yes | Narcotic (CDSA I) | 1 | REMIFENTANIL (REMIFENTANIL HYDROCHLORIDE) | 2 MG |
Cancelled Post Market | 02230411 | ABBVIE CORPORATION | ULTIVA | Human | Yes | Narcotic (CDSA I) | 1 | REMIFENTANIL (REMIFENTANIL HYDROCHLORIDE) | 5 MG |
Marketed | 02458039 | ABBVIE CORPORATION | VENCLEXTA | Human | Yes | Prescription | 1 | VENETOCLAX | 10 MG |
Marketed | 02458047 | ABBVIE CORPORATION | VENCLEXTA | Human | Yes | Prescription | 1 | VENETOCLAX | 50 MG |
Marketed | 02458055 | ABBVIE CORPORATION | VENCLEXTA | Human | Yes | Prescription | 1 | VENETOCLAX | 100 MG |
Marketed | 02458063 | ABBVIE CORPORATION | VENCLEXTA | Human | Yes | Prescription | 3 | VENETOCLAX | 10 MG |
Marketed | 02460890 | ABBVIE CORPORATION | VIBERZI | Human | Yes | Prescription | 1 | ELUXADOLINE | 75 MG |
Marketed | 02460904 | ABBVIE CORPORATION | VIBERZI | Human | Yes | Prescription | 1 | ELUXADOLINE | 100 MG |
Marketed | 02443724 | ABBVIE CORPORATION | VIIBRYD | Human | Yes | Prescription | 1 | VILAZODONE HYDROCHLORIDE | 10 MG |
Marketed | 02443732 | ABBVIE CORPORATION | VIIBRYD | Human | Yes | Prescription | 1 | VILAZODONE HYDROCHLORIDE | 20 MG |
Marketed | 02443740 | ABBVIE CORPORATION | VIIBRYD | Human | Yes | Prescription | 1 | VILAZODONE HYDROCHLORIDE | 40 MG |
Cancelled Post Market | 02443759 | ABBVIE CORPORATION | VIIBRYD | Human | Yes | Prescription | 2 | VILAZODONE HYDROCHLORIDE | 10 MG |
Marketed | 02526794 | ABBVIE CORPORATION | VRAYLAR | Human | Yes | Prescription | 1 | CARIPRAZINE (CARIPRAZINE HYDROCHLORIDE) | 1.5 MG |
Marketed | 02526808 | ABBVIE CORPORATION | VRAYLAR | Human | Yes | Prescription | 1 | CARIPRAZINE (CARIPRAZINE HYDROCHLORIDE) | 3 MG |
Marketed | 02526816 | ABBVIE CORPORATION | VRAYLAR | Human | Yes | Prescription | 1 | CARIPRAZINE (CARIPRAZINE HYDROCHLORIDE) | 4.5 MG |
Marketed | 02526824 | ABBVIE CORPORATION | VRAYLAR | Human | Yes | Prescription | 1 | CARIPRAZINE (CARIPRAZINE HYDROCHLORIDE) | 6 MG |
Marketed | 02537702 | ABBVIE CORPORATION | VYALEV | Human | Yes | Prescription | 2 | FOSLEVODOPA | 240 MG / ML |
Cancelled Post Market | 02266202 | ABBVIE CORPORATION | ZEMPLAR | Human | Yes | Prescription | 1 | PARICALCITOL | 5 MCG / ML |
Marketed | 02257270 | ABBVIE CORPORATION | ZYMAR | Human | Yes | Prescription | 1 | GATIFLOXACIN | 0.3 % / W/V |
Application information
Related information
Contact us
Version 4.0.3